Europe Gastrointestinal Drugs Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Gastrointestinal Drugs Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Gastrointestinal Drugs Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Gastrointestinal Drugs Market Regional Analysis

6.2 Europe Gastrointestinal Drugs Market Revenue 2021-2031 (US$ Million)

6.3 Europe Gastrointestinal Drugs Market Forecast Analysis

7. Europe Gastrointestinal Drugs Market Analysis – by Drug Class

7.1 Biologics

7.1.1 Overview
7.1.2 Biologics: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Antidiarrheal and Laxatives

7.2.1 Overview
7.2.2 Antidiarrheal and Laxatives: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Acid Neutralizers

7.3.1 Overview
7.3.2 Acid Neutralizers: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Anti-inflammatory Drugs

7.4.1 Overview
7.4.2 Anti-inflammatory Drugs: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Antiemetic and Antinauseants

7.5.1 Overview
7.5.2 Antiemetic and Antinauseants: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Others

7.6.1 Overview
7.6.2 Others: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Gastrointestinal Drugs Market Analysis – by Application

8.1 Irritable Bowel Syndrome

8.1.1 Overview
8.1.2 Irritable Bowel Syndrome: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Inflammatory Ulcerative Colitis

8.2.1 Overview
8.2.2 Inflammatory Ulcerative Colitis: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Crohn\'s Disease

8.3.1 Overview
8.3.2 Crohn\'s Disease: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Gastroenteritis

8.4.1 Overview
8.4.2 Gastroenteritis: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Celiac Disease

8.5.1 Overview
8.5.2 Celiac Disease: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Others

8.6.1 Overview
8.6.2 Others: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Gastrointestinal Drugs Market Analysis – by Route Of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Parenteral

9.2.1 Overview
9.2.2 Parenteral: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Gastrointestinal Drugs Market Analysis – by Distribution Channel

10.1 Hospital Pharmacies

10.1.1 Overview
10.1.2 Hospital Pharmacies: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Retail Pharmacies

10.2.1 Overview
10.2.2 Retail Pharmacies: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Online Pharmacies

10.3.1 Overview
10.3.2 Online Pharmacies: Europe Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. Europe Gastrointestinal Drugs Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Gastrointestinal Drugs Market Breakdown, by Key Country, 2024 and 2031 (%)
11.2.1.1 Europe Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 UK: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.1.2 UK: Europe Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.1.3 UK: Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.1.4 UK: Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.2.1.2 Germany: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Germany: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.2.2 Germany: Europe Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.2.3 Germany: Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.2.4 Germany: Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.2.1.3 France: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 France: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.3.2 France: Europe Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.3.3 France: Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.3.4 France: Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.2.1.4 Italy: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 Italy: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.4.2 Italy: Europe Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.4.3 Italy: Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.4.4 Italy: Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.2.1.5 Spain: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 Spain: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.5.2 Spain: Europe Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.5.3 Spain: Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.5.4 Spain: Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.2.1.6 Rest of Europe: Europe Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.6.2 Rest of Europe: Europe Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.6.3 Rest of Europe: Europe Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.6.4 Rest of Europe: Europe Gastrointestinal Drugs Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Sanofi SA

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 GSK Plc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Johnson & Johnson

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Bausch Health Companies Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 AstraZeneca Plc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Takeda Pharmaceutical Co Ltd

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 AbbVie Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Bayer AG

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Celltrion Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Pfizer Inc

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Gastrointestinal Drugs Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis